1. Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma;Olsen;J Clin Oncol,2001
2. Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results;Duvic;J Clin Oncol,2001
3. Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma;Duvic;Arch Dermatol,2001
4. Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma;Olsen;J Clin Oncol,2007
5. Kim Y, Whittaker S, Demierre MF, et al. Clinically significant responses achieved with romidepsin in treatment-refractory cutaneous t-cell lymphoma: final results from a phase 2b, international, multicenter, registration study. Paper presented at: 50th American Society of Hematology Annual Meeting and Exposition; December 6-9, 2008; San Francisco, CA. Abstracts 112:263.